MEI Pharma, Inc. announced the appointment of Mr. Sujay Kango to its board of directors effective November 22, 2021. Mr. Sujay Kango is an experienced executive with more than 25 years of experience in the pharmaceutical and biotechnology industries. He joined Acceleron Pharma in 2018, where he most recently served as the executive vice president and chief commercial officer and was responsible for establishing the company?s North America commercial presence for luspatercept. The Company also announced that after many years of service and dedication, Kevan Clemens, Ph.D., has resigned from the company?s board of directors and the compensation committee of the board of directors, effective November 22, 2021. Dr. Clemens served as a member of the company?s board of directors since December 2014.